EAACI Congress 2025 Back

13 - 16 June 2025 Glasgow, United Kingdom

Giorgio W Canonica

Italy

Giorgio W Canonica

Distinguished Professor & Senior Consultant Personalized Medicine Asthma & Allergy at Humanitas University & Research Hospital Milano Italy

Topics of Research:

Asthma Biologics, Allergen ImmunoTherapy Personalized Medicine

H index 143; Citations >100.000

https://orcid.org/0000-0001-8467-2557

Sessions

Friday 13 Jun

10:07 - 10:14 Efficacy of 300IR house dust mite sublingual immunotherapy tablet on steroid sparing in patients with house dust mite allergic rhinitis: an in-depth analysis

14:15 - 14:45 Translating Science into Clinical Impact: The Journey of Allergy Research

Sunday 15 Jun

15:15 - 15:45 Single Inhaler Triple Therapy: looking into the Achievable Outcomes"

16:45 - 16:57
100176 Real-World Effectiveness of Dupilumab vs. Other Biologics in Achieving Clinical Remission as Assessed by a Composite Measure of Selected Asthma Outcomes in Patients with Severe Asthma: EU ADVANTAGE

18:54 - 19:06 Baseline Predictors of Multicomponent Clinical Remission Following Dupilumab Treatment in Patients With Moderate-to-Severe Asthma

19:42 - 19:54 Mepolizumab Improves and Sustains Asthma Control and Lung Function in Patients with Severe Asthma Independent of Baseline Blood Eosinophil Count in the Real World: Results from REALITI-A at 2 Years

EAACI Congress 2025 Back

Sessions

Share this pen